Cargando…
NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues
Autores principales: | Mushtaq, Kamran, Khan, Muhammad Umair, Iqbal, Fatima, Alsoub, Deema Hussam, Chaudhry, Hammad Shabir, Ata, Fateen, Iqbal, Phool, Elfert, Khaled, Balaraju, Girisha, Almaslamani, Muna, Al-Ejji, Khalid, AlKaabi, Saad, Kamel, Yasser Medhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836329/ https://www.ncbi.nlm.nih.gov/pubmed/33223215 http://dx.doi.org/10.1016/j.jhep.2020.09.006 |
Ejemplares similares
-
Sa1317: HYPERLIPASEMIA IS ASSOCIATED WITH INCREASED MORTALITY IN COVID-19 HOSPITALIZED PATIENTS: A RETROSPECTIVE STUDY
por: Elfert, Khaled, et al.
Publicado: (2022) -
Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar
por: Khan, Muhammad Umair, et al.
Publicado: (2021) -
mRNA COVID-19 vaccine effectiveness in liver transplant patients
por: Khan, Muhammad, et al.
Publicado: (2022) -
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Khan, Muhammad, et al.
Publicado: (2022) -
Should We Rely on Screening Tests for Further Management Alone in Polymerase Chain Reaction Negative COVID-19 Patients? A Case Series
por: Iqbal, Phool, et al.
Publicado: (2020)